This study will assess the impact of centralized outreach on lung cancer screening completion among individuals served by Federally Qualified Health Centers.
This will be a two-arm, parallel, pragmatic randomized controlled trial (RCT) to evaluate the effectiveness of a centralized patient outreach strategy in increasing lung cancer screening (LCS) completion among populations served by Federally Qualified Health Centers (FQHCs). This study will randomize individuals potentially eligible for LCS (50-80 years, current or past smokers) to receive centralized patient outreach in addition to usual care (outreach arm) and usual care alone (usual care arm). Individuals assigned to the outreach arm will receive centralized patient outreach from the Lung screening team through a letter followed by up to three attempts of telephone contact. Individuals assigned to the usual care arm will not receive any contact during the study period and the referral for LCS will be made at the treating physician's discretion.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Enrollment
2,000
Centralized patient outreach for lung cancer screening will be conducted by the lung screening team and will consist of a letter followed by telephone contact. One week following the mail invitation, a senior patient coordinator (SPC) will make telephone contact with individuals to pre-screen eligibility determination based on pack-year smoking history. Up to three telephone contact attempts will be made within two weeks.
Weill Cornell Medicine
New York, New York, United States
Proportion of individuals completing low-dose CT (LDCT) within 15 months of randomization.
Time frame: Within 15 months of randomization
LDCT scan findings: Lung Imaging Reporting and Data System (Lung-RADS)
Proportion of individuals with Lung-RADS 1, 2, 3, and 4
Time frame: Within 15 months of randomization
LDCT incident findings
Proportion of individuals with incident findings on LDCT (including moderate to severe coronary artery calcification, lung-mediastinal findings, moderate to severe emphysema, and abdominal findings)
Time frame: Within 15 months of randomization
Follow-up care
Proportion of individuals receiving a biopsy or lung cancer treatment
Time frame: Within 6 months after screening
Average costs of implementing centralized outreach per individual
Time frame: Within 15 months of randomization
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.